Siemens Healthineers Immulite 2000 Syphilis Screen Recall

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on September 9, 2026 and geographically references Worldwide. The FDA classifies this as a Class II recall, with the stated reason "Syphilis Screen assay may contain a negative patient bias resulting in low reactive patient results being reported as nonreactive.", distributed worldwide - us nationwide distribution in the states of fl, nj, ny and the countries of austria, azerbaijan, belgium, brazil, chile, colombia, cura-ao, st.¿eus cyprus, france, germany, italy, kazakhstan, latvia, lithuania, netherlands, romania, russian¿fed., saudi¿arabia, slovakia, slovenia, south¿africa, spain, u.a.e., ukraine, united¿kingdom, uzbekistan.¿¿¿¿¿. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.